Proposed Disposal of Intrasense’s Myrian® Business to EDL and Acceleration of Intrasense’s Transformation into a Pure-Player Artificial Intelligence Company Dedicated to Oncology. A transformative transaction that would enable Intrasense to focus its resources on the development of its DUOnco™ platform and the implementation of its IN2ONCO strategic plan

Intrasense, a French specialist in AI-enhanced medical imaging solutions supporting diagnosis, clinical decision-making and therapeutic monitoring ("Intrasense" or the "Company"), announces that it has received a firm and irrevocable offer from EDL for the acquisition of its Myrian® business.

Retour